The shift from myeloid to lymphatic phenotype may be due to the increased BCR/ABL kinase activity in the presence of p96ABL/BCR as it has been already shown by Jones and co-worker for the development of myeloid or lymphatic BC in patients with CML [10]. This evidence concerns the gene ABL1 and breast cancer.